Cabot (NYSE:CBT) Updates FY 2026 Earnings Guidance
by Doug Wharley · The Cerbat GemCabot (NYSE:CBT – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 6.000-6.50 for the period, compared to the consensus earnings per share estimate of 6.240. The company issued revenue guidance of -.
Cabot Price Performance
CBT stock traded up $3.12 during midday trading on Tuesday, reaching $78.97. The stock had a trading volume of 500,538 shares, compared to its average volume of 433,035. The company’s fifty day simple moving average is $73.60 and its 200 day simple moving average is $70.18. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. The company has a market cap of $4.12 billion, a price-to-earnings ratio of 13.83, a price-to-earnings-growth ratio of 10.20 and a beta of 0.78. Cabot has a 52-week low of $58.33 and a 52-week high of $83.71.
Cabot (NYSE:CBT – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 22.82% and a net margin of 8.62%.Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, sell-side analysts predict that Cabot will post 6.27 earnings per share for the current fiscal year.
Cabot Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be issued a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Friday, May 29th. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is 31.52%.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on CBT shares. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Mizuho set a $75.00 target price on Cabot and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 target price on shares of Cabot in a research note on Wednesday, February 4th. Finally, UBS Group raised their target price on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $73.75.
Read Our Latest Research Report on CBT
Institutional Trading of Cabot
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. T. Rowe Price Investment Management Inc. increased its stake in shares of Cabot by 1.8% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 547,410 shares of the specialty chemicals company’s stock worth $36,283,000 after acquiring an additional 9,816 shares during the last quarter. Caitlin John LLC increased its position in shares of Cabot by 29.3% during the 4th quarter. Caitlin John LLC now owns 3,137 shares of the specialty chemicals company’s stock worth $208,000 after purchasing an additional 710 shares during the last quarter. Beacon Pointe Advisors LLC acquired a new stake in shares of Cabot during the 4th quarter worth about $1,640,000. State of Tennessee Department of Treasury increased its position in shares of Cabot by 15.4% during the 4th quarter. State of Tennessee Department of Treasury now owns 20,628 shares of the specialty chemicals company’s stock worth $1,489,000 after purchasing an additional 2,748 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of Cabot by 5.6% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after purchasing an additional 124,613 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.